Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CryoLife BioGlue Vascular Approval To Double Sales Of The Adhesive In 2002

This article was originally published in The Gray Sheet

Executive Summary

FDA approval of CryoLife's BioGlue for vascular repair procedures, announced Dec. 4, is expected to roughly double sales of the surgical adhesive to $22-24 mil. in 2002, the firm says

You may also be interested in...



CryoLife BioGlue Gel Formulation Among 11 Related Applications In Pipeline

CryoLife is opting not to pursue a general surgery indication in the U.S. for its BioGlue surgical adhesive

CryoLife BioGlue Gel Formulation Among 11 Related Applications In Pipeline

CryoLife is opting not to pursue a general surgery indication in the U.S. for its BioGlue surgical adhesive

CryoLife BioGlue PMA Clears FDA Panel With Minimal Conditions

One member of FDA's Circulatory System Devices Panel suggested that the agency look into the number of transfusions performed when surgeons use CryoLife's BioGlue surgical adhesive, but stopped short of recommending it as a condition of approval during the panel's Sept. 11 review of the product.

Related Content

UsernamePublicRestriction

Register

MT015806

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel